Singapore markets closed

Elicio Therapeutics, Inc. (ELTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.68+0.06 (+0.91%)
At close: 04:00PM EDT
6.68 -0.00 (-0.02%)
After hours: 04:17PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
25,924
23,849
18,103
17,932
12,720
Selling general and administrative
12,257
11,896
5,630
7,543
3,001
Total operating expenses
38,181
35,745
23,733
25,475
15,721
Operating income or loss
-38,181
-35,745
-23,733
-25,475
-15,721
Interest expense
753
1,059
3,597
876.442
-
Total other income/expenses net
6
1,236
-943
-52.962
-
Income before tax
-38,993
-35,195
-28,208
-26,401
-15,712
Income from continuing operations
-38,993
-35,195
-28,208
-26,401
-15,712
Net income
-38,993
-35,195
-28,208
-26,401
-15,712
Net income available to common shareholders
-38,993
-35,195
-28,208
-26,401
-15,712
Basic EPS
-3.93
-6.96
-88.84
-83.91
-1.93
Diluted EPS
-3.93
-6.96
-88.84
-83.91
-1.93
Basic average shares
8,378
5,056
317.512
314.619
8,147
Diluted average shares
8,378
5,056
317.512
314.619
8,147